Skip to main content
Home

Main navigation

  • Top stories
  • Health
  • Crime
  • Politics
  • Business
  • Tech
  • Culture
  • Sports
  • Weird
  • 1-1-2
Image
Janssen vaccine
Janssen vaccine - Credit: kshu / DepositPhotos - License: DepositPhotos
Health
Janssen
Johnson & Johnson
vaccine
Covid-19
Coronavirus
vaccination plan
Pfizer
AstraZeneca
Moderna
Novavax
Sunday, 31 January 2021 - 14:30
Share this:
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • reddit

Janssen vaccine produced in the Netherlands shows 66 percent efficacy

The vaccine produced by Belgian company Janssen shows a single-dose efficacy of 66 percent. This is lower than the other vaccines that have thus far been approved, however, this may not matter too much.

The vaccine developed in Leiden under parent company Johnson & Johnson appears to be less effective than others. The first vaccine that was approved, developed by Pfizer/BionTech, shows 95 percent efficacy. AstraZeneca’s vaccine has an average efficacy rate of 70 percent, and the vaccine developed by Moderna shows an efficacy rate of 92 percent. On Friday, US-based company Novavax announced that the phase three trial of its vaccine indicated an efficacy level between 86 to 89 percent.

However, experts say that this may not necessarily be a disadvantage. In an interview with EenVandaag, virologist Marjolein Kikkert explains that the mix of different vaccines may in fact be an advantage. “I think it is very beneficial that we will soon have a set of vaccines that each have their strengths and weaknesses so that they can complement each other.”

One of the main advantages of the Janssen vaccine is that the 66 percent immunity rate can be achieved after one jab, whereas the other vaccines currently on the market require two doses. Moreover, this vaccine can be stored at four degrees, which is fridge temperature. “Logistically, this means that it will be much easier to distribute than, for example, a vaccine that needs to be stored at minus 80 degrees,” explains Kikkert.

The virologist added that these percentages must be understood in relative terms. She argues that two-thirds of the people who will receive the Janssen vaccine will “become completely immune.” For the remaining one-third, “it will significantly reduce the risk of becoming severely ill,” she adds.

The combination of various vaccines may thus lead to the desired ultimate goal of herd immunity.


Follow us:

Latest stories

  • Trade union announces more civil servants' strikes, including in The Hague
  • Nine suspects arrested in Netherlands for 50 ATM bombings in Germany
  • Student orgs. want temporary, not permanent limit on international students
  • Doxxing ban likely to win Dutch parliament majority today
  • Shell books record profit of $42.3 billion in 2022
  • Amsterdam to ban some tour buses from city center from 2024

Top stories

  • Nine suspects arrested in Netherlands for 50 ATM bombings in Germany
  • Amsterdam to ban some tour buses from city center from 2024
  • Police missed many signals in run-up to attorney, crime journalist's murders: report
  • Public transport strike: No trains running in Friesland, part of Groningen
  • Dutch mad cow disease case concerns variant that is less dangerous for humans
  • Catering sector to blacklist people who misbehave in clubs, bars

© 2012-2023, NL Times, All rights reserved.

Footer menu

  • Privacy
  • Contact
  • Partner content